IBDEI2LR ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,308,0)
 ;;=CONSULTATIONS^4^25
 ;;^UTILITY(U,$J,358.4,309,0)
 ;;=PROVIDER WEEKLY VISIT^1^25
 ;;^UTILITY(U,$J,358.4,310,0)
 ;;=ACCESS^2^26
 ;;^UTILITY(U,$J,358.4,311,0)
 ;;=DIALYSIS PROCEDURES^3^26
 ;;^UTILITY(U,$J,358.4,312,0)
 ;;=ESRD HOME SERVICES^4^26
 ;;^UTILITY(U,$J,358.4,313,0)
 ;;=HEMODIALYSIS OVERSIGHT^5^26
 ;;^UTILITY(U,$J,358.4,314,0)
 ;;=LAB^7^26
 ;;^UTILITY(U,$J,358.4,315,0)
 ;;=MEDICATIONS^8^26
 ;;^UTILITY(U,$J,358.4,316,0)
 ;;=MONITORING^9^26
 ;;^UTILITY(U,$J,358.4,317,0)
 ;;=OTHER^10^26
 ;;^UTILITY(U,$J,358.4,318,0)
 ;;=PATIENT EDUCATION/TEACHING^11^26
 ;;^UTILITY(U,$J,358.4,319,0)
 ;;=PATIENT MANAGEMENT^12^26
 ;;^UTILITY(U,$J,358.4,320,0)
 ;;=SUPPLIES^13^26
 ;;^UTILITY(U,$J,358.4,321,0)
 ;;=VACCINATIONS^14^26
 ;;^UTILITY(U,$J,358.4,322,0)
 ;;=DAILY DIALYSIS TXMT^1^26
 ;;^UTILITY(U,$J,358.4,323,0)
 ;;=INPATIENT DIALYSIS^6^26
 ;;^UTILITY(U,$J,358.4,324,0)
 ;;=HEMODIALYSIS-ESRD^14^27
 ;;^UTILITY(U,$J,358.4,325,0)
 ;;=PERITONEAL DIALYSIS ENCOUNTER^23^27
 ;;^UTILITY(U,$J,358.4,326,0)
 ;;=CARDIOLOGY/CARDIORENAL SYNDROME^2^27
 ;;^UTILITY(U,$J,358.4,327,0)
 ;;=COMPLICATIONS/OTHER^4^27
 ;;^UTILITY(U,$J,358.4,328,0)
 ;;=CYSTIC KIDNEY DISEASE^5^27
 ;;^UTILITY(U,$J,358.4,329,0)
 ;;=DIABETES/DIABETIC RENAL DISEASE^6^27
 ;;^UTILITY(U,$J,358.4,330,0)
 ;;=FLUID/ELECTROLYTE DISORDER^8^27
 ;;^UTILITY(U,$J,358.4,331,0)
 ;;=GENERAL SYMPTOMS^9^27
 ;;^UTILITY(U,$J,358.4,332,0)
 ;;=GENITAL/URINARY^10^27
 ;;^UTILITY(U,$J,358.4,333,0)
 ;;=HEMATOLOGY^12^27
 ;;^UTILITY(U,$J,358.4,334,0)
 ;;=HYPERTENSION^15^27
 ;;^UTILITY(U,$J,358.4,335,0)
 ;;=INFECTIOUS DISEASE^16^27
 ;;^UTILITY(U,$J,358.4,336,0)
 ;;=NEPHRITIS GLUMERULONEPHRITIS^18^27
 ;;^UTILITY(U,$J,358.4,337,0)
 ;;=NEPHRITIS INTERSTITIAL^19^27
 ;;^UTILITY(U,$J,358.4,338,0)
 ;;=NEPHROTIC SYNDROME^21^27
 ;;^UTILITY(U,$J,358.4,339,0)
 ;;=OBSTRUCTIVE UROPATHY^22^27
 ;;^UTILITY(U,$J,358.4,340,0)
 ;;=TRANSPLANT^25^27
 ;;^UTILITY(U,$J,358.4,341,0)
 ;;=CKD/KIDNEY DISEASE^3^27
 ;;^UTILITY(U,$J,358.4,342,0)
 ;;=HEMODIALYSIS-AKI^13^27
 ;;^UTILITY(U,$J,358.4,343,0)
 ;;=ACUTE KIDNEY INJURY^1^27
 ;;^UTILITY(U,$J,358.4,344,0)
 ;;=GLOMERULAR DISEASE^11^27
 ;;^UTILITY(U,$J,358.4,345,0)
 ;;=KIDNEY INVOLVMNT IN SYSTEMIC DISEASE^17^27
 ;;^UTILITY(U,$J,358.4,346,0)
 ;;=NEPHROLITHASIS^20^27
 ;;^UTILITY(U,$J,358.4,347,0)
 ;;=POISONING & INTOXICATIONS^24^27
 ;;^UTILITY(U,$J,358.4,348,0)
 ;;=DIALYSIS^7^27
 ;;^UTILITY(U,$J,358.4,349,0)
 ;;=IMMUNIZATION^10^28
 ;;^UTILITY(U,$J,358.4,350,0)
 ;;=INJECTION/INFUSION^12^28
 ;;^UTILITY(U,$J,358.4,351,0)
 ;;=SKIN TEST^26^28
 ;;^UTILITY(U,$J,358.4,352,0)
 ;;=NURSING PROCEDURES^18^28
 ;;^UTILITY(U,$J,358.4,353,0)
 ;;=SPLINTS^27^28
 ;;^UTILITY(U,$J,358.4,354,0)
 ;;=REPAIR-SIMPLE SCALP,NK,TRUNK,GENITALIA^24^28
 ;;^UTILITY(U,$J,358.4,355,0)
 ;;=REPAIR-SIMPLE FACE,MUCOUS^23^28
 ;;^UTILITY(U,$J,358.4,356,0)
 ;;=MODERATE SEDATION^15^28
 ;;^UTILITY(U,$J,358.4,357,0)
 ;;=INTEGUMENTARY SYSTEM^13^28
 ;;^UTILITY(U,$J,358.4,358,0)
 ;;=MUSCULOSKELETAL^16^28
 ;;^UTILITY(U,$J,358.4,359,0)
 ;;=CASTS/STRAPS^4^28
 ;;^UTILITY(U,$J,358.4,360,0)
 ;;=RESPIRATORY SYSTEM^25^28
 ;;^UTILITY(U,$J,358.4,361,0)
 ;;=CARDIOVASCULAR SYSTEM^3^28
 ;;^UTILITY(U,$J,358.4,362,0)
 ;;=DIGESTIVE SYSTEM^7^28
 ;;^UTILITY(U,$J,358.4,363,0)
 ;;=URINARY SYSTEM^28^28
 ;;^UTILITY(U,$J,358.4,364,0)
 ;;=MALE GENITAL SYSTEM^14^28
 ;;^UTILITY(U,$J,358.4,365,0)
 ;;=FEMALE GENITAL SYSTEM^9^28
 ;;^UTILITY(U,$J,358.4,366,0)
 ;;=NERVOUS SYSTEM^17^28
 ;;^UTILITY(U,$J,358.4,367,0)
 ;;=EYE & OCULAR ADNEXA^8^28
 ;;^UTILITY(U,$J,358.4,368,0)
 ;;=AUDITORY SYSTEM^1^28
 ;;^UTILITY(U,$J,358.4,369,0)
 ;;=REPAIR-INTER SCALP/NECK/TRNK/EXTREM^22^28
